Summa Health System
Records under this name other than patents Summa Health System holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Summa Health System
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,050,265 | Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,273,208 | CAMKK1 as a Novel Regenerative Therapeutic Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,583,571 | Stromal Derived Factor 1 and Its Use in the Prevention and Treatment of Erectile Dysfunction Formerly held In force · High confidence | In force | High confidence | |
| US 10,092,349 | Variable-Frequency Stimulator for Electrosurgery Formerly held Lapsed on the fee record Ended Oct 9, 2026 · Medium confidence | Lapsed on the fee record | Ended Oct 9, 2026 | Medium confidence |
| US 8,507,555 | Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone Lapsed on the fee record Ended Aug 13, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 13, 2025 | USPTO record |
| US 7,091,241 | Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined vitamins C and K3 Formerly held Term ended Term ended Apr 16, 2023 · USPTO record | Term ended | Term ended Apr 16, 2023 | USPTO record |
| US 8,680,142 | Ascorbate, vitamin K3 and hydroxytolans in the treatment of cancer Lapsed on the fee record Ended Mar 25, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 25, 2022 | USPTO record |
| US 8,751,254 | Method and apparatus for monitoring and systematizing rehabilitation data Lapsed on the fee record Ended Jun 10, 2018 · USPTO record | Lapsed on the fee record | Ended Jun 10, 2018 | USPTO record |
| US 5,460,970 | Separation of acetaldehyde-induced hemoglobin (Hb A.sub.1-AcH) Term ended Term ended no later than Oct 24, 2015 · Low confidence | Term ended | Term ended no later than Oct 24, 2015 | Low confidence |